Effect of Different Levofloxacin Doses on QTc Interval Prolongation in Multidrug-Resistant Tuberculosis Patients Treated with the 9-Month All-Oral Regimen
Introduction: The World Health Organization (WHO) has recommended the 9-month all-oral regimen for multidrug-resistant tuberculosis (MDR-TB) treatment. This regimen is expected to increase the treatment success rate. Bedaquiline, levofloxacin, and clofazimine are QT-prolonging drugs included in the...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Universitas Airlangga
2024-09-01
|
Series: | Jurnal Respirasi |
Subjects: | |
Online Access: | https://e-journal.unair.ac.id/JR/article/view/56315 |